Imagine going to the doctor, and having a blood test to determine if that recent fall or accident caused brain damage, and if so how much. That’s what Banyan Biomarkers is attempting to do. They are working to develop “a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and facilitate the diagnosis and management of head injured patients.”
To that end, Banyan Biomarkers has just recently announced that the U.S. Patent and Trademark Office have granted U.S. Patent No. 7,396,654 B2 “Neural Proteins as Biomarkers for Traumatic Brain Injury”. The patent is licensed exclusively by Banyan Biomarkers from the University of Florida and it covers the “detection of certain neuronal protein markers found in the blood of patients suffering from neural injury and /or neuronal damage”.